Suprapubic Aspiration Versus Urinary Catheterization In Neonates. (SPA)
| Tracking Information | |||||
|---|---|---|---|---|---|
| First Received Date ICMJE | November 7, 2012 | ||||
| Last Updated Date | March 5, 2013 | ||||
| Start Date ICMJE | April 2013 | ||||
| Estimated Primary Completion Date | May 2015 (final data collection date for primary outcome measure) | ||||
| Current Primary Outcome Measures ICMJE |
Number of contaminated urine samples per SPA and UC [ Time Frame: April 2013 - March 2015 ] [ Designated as safety issue: No ] For SPA samples, urine contamination will be defined as the growth of two or more micro-organisms (any number of colonies per each microorganism) or the growth of Candida species plus growth of any other microorganism. For UC samples, urine contamination will be defined as the growth of two or more micro-organisms (any number of colonies per each microorganism) or any growth <10^4 colony forming unit(CFU)/ml or the growth of Candida species plus growth of any other microorganism. The different cut-off used for contamination between UC and SPA samples stems from the fact that the UC procedure is not sterile in the neonatal population. Note that a bacterial load of <10^3 CFU/mL (e.g. 10^1 or 10^2 CFU/mL) does not grow in the media of either laboratory where our study samples are being cultured. Further sensitivity analyses will be performed on this outcome measure. |
||||
| Original Primary Outcome Measures ICMJE |
Number of contaminated urine samples per UC and SPA. [ Time Frame: Up to two years ] [ Designated as safety issue: No ] Urine contamination will be defined as growth of two or more micro-organisms (any number of colonies per each microorganism)per the SPA samples, and as the growth of two or more micro-organism (any number of colonies per each microorganism) and/or any growth <104 colony forming unit(CFU)/ml per UC samples. Growth of Candida species plus another organism will be considered a contamination. |
||||
| Change History | Complete list of historical versions of study NCT01726166 on ClinicalTrials.gov Archive Site | ||||
| Current Secondary Outcome Measures ICMJE |
|
||||
| Original Secondary Outcome Measures ICMJE |
Number of successful attempts in obtaining adequate urine samples per UC, and SPA. [ Time Frame: Up to two years ] [ Designated as safety issue: No ] Successful withdrawal of urine is defined as obtaining 0.5ml of urine during an attempt at SPA or UC. This is the quantity required by our laboratory for urine culture. |
||||
| Current Other Outcome Measures ICMJE | Not Provided | ||||
| Original Other Outcome Measures ICMJE |
Number of participants with Complications per UC and SPA as a measure of safety [ Time Frame: Up to two years ] [ Designated as safety issue: Yes ] | ||||
| Descriptive Information | |||||
| Brief Title ICMJE | Suprapubic Aspiration Versus Urinary Catheterization In Neonates. | ||||
| Official Title ICMJE | A Randomized Controlled Trial: Suprapubic Aspiration Versus Urinary Catheterization in the Neonatal Intensive Care Unit. | ||||
| Brief Summary | Urinary tract infection (UTI) is relatively common in infants, with an occurence rate of up to 10%. It is more frequent in male and preterm newborn infants and can lead to significant problems in infants including blood infections, kidney infections, and kidney scarring which can affect how the kidneys work later in life. Analysis of collected urine for the presence of bacteria or fungus is the only way to make a certain UTI diagnosis. Urine culture results may take 24 to 48 hours to become available. Sterile collection of urine can be achieved in newborn infants by urinary catheterization (UC) where a catheter is passed through the urethra into the bladder, suprapubic aspiration (SPA) where a needle is inserted into the bladder through the abdominal wall, or 'clean catch' where urine is collected into a sterile bottle as the baby urinates during preparation for UC. The main advantage of SPA is that it bypasses the bacteria that normally resides in the urethral opening, thus minimizing the risk of contamination. Some studies have suggested that SPA is better than UC for collecting urine in a sterile fashion in the neonate due to the difficulty of doing sterile UC in small infants resulting in more contaminated samples (also called a false-positive urine culture); there are some problems with the way these studies were done so there is still no clear best choice. UC is commonly used in many Neonatal Intensive Care Units (NICU) as it is considered less invasive, can be done by the nursing staff, and generally has a higher chance of obtaining urine. SPA is a simple and safe alternative and, although some studies suggest that it is more painful than UC, it it performed more quickly. The reported success rate for SPA is variable, but is greatly increased when an ultrasound confirms urine in the bladder before doing the SPA. The question remains: what is the best method for sterile collection of urine in newborns and young infants? In this study, the investigators will try to answer this question by collecting urine from infants admitted to our NICU using either ultrasound guided SPA or UC and then comparing the contamination rates between these two methods. The investigators hypothesize that SPA will result in less contamination of urine samples. The investigators also hypothesize that there will be more success in obtaining an adequate urine sample (0.5 ml) by SPA, SPA will be quicker to perform, and that there will be no difference in associated complication rates between SPA and UC. |
||||
| Detailed Description | Not Provided | ||||
| Study Type ICMJE | Interventional | ||||
| Study Phase | Not Provided | ||||
| Study Design ICMJE | Allocation: Randomized Intervention Model: Parallel Assignment Masking: Open Label Primary Purpose: Diagnostic |
||||
| Condition ICMJE | Neonatal Urinary Tract Infection | ||||
| Intervention ICMJE |
|
||||
| Study Arm (s) |
|
||||
| Publications * | Not Provided | ||||
|
* Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline. |
|||||
| Recruitment Information | |||||
| Recruitment Status ICMJE | Not yet recruiting | ||||
| Estimated Enrollment ICMJE | 165 | ||||
| Estimated Completion Date | May 2015 | ||||
| Estimated Primary Completion Date | May 2015 (final data collection date for primary outcome measure) | ||||
| Eligibility Criteria ICMJE | Inclusion criteria (to be approached for consent): -All infants who are admitted to the NICU and are not known to have the exclusion criteria listed below at the time of admission Exclusion criteria (to be approached for consent):
Inclusion criteria (prior to randomization): -All infants who are greater than 72 hours of age, who are being investigated for a possible UTI, and have been consented will be eligible for randomization Exclusion criteria (prior to randomization):
|
||||
| Gender | Both | ||||
| Ages | up to 12 Months | ||||
| Accepts Healthy Volunteers | No | ||||
| Contacts ICMJE |
|
||||
| Location Countries ICMJE | Canada | ||||
| Administrative Information | |||||
| NCT Number ICMJE | NCT01726166 | ||||
| Other Study ID Numbers ICMJE | 2011813-01H | ||||
| Has Data Monitoring Committee | No | ||||
| Responsible Party | Dr. Gregory Moore, Children's Hospital of Eastern Ontario | ||||
| Study Sponsor ICMJE | Children's Hospital of Eastern Ontario | ||||
| Collaborators ICMJE | The Physicians' Services Incorporated Foundation | ||||
| Investigators ICMJE |
|
||||
| Information Provided By | Children's Hospital of Eastern Ontario | ||||
| Verification Date | March 2013 | ||||
|
ICMJE Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP |
|||||